VNOV (VitaNova Life Sciences) Total Inventories: $0.11 Mil (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

VNOV VitaNova Life Sciences Corp VNOV
51 GF Score
Price $1.38
GF Value $5.95
! 1 Warning Sign
View Full Analysis

What is VitaNova Life Sciences Total Inventories?

VitaNova Life Sciences VNOV 51 Total Inventories is $0.11 Mil as of Apr. 2026. GuruFocus rates VNOV with a GF Score™ of 51/100 and a GF Value™ of $5.95. The stock has 1 warning sign investors should review.

VitaNova Life Sciences's total inventories for the quarter that ended in Apr. 2026 was $0.11 Mil. VitaNova Life Sciences's average total inventories from the quarter that ended in Jan. 2026 to the quarter that ended in Apr. 2026 was $0.12 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. VitaNova Life Sciences's Net-Net Working Capital per share for the quarter that ended in Apr. 2026 was $0.22.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. VitaNova Life Sciences's Days Inventory for the three months ended in Apr. 2026 was 7.08.

Inventory Turnover measures how fast the company turns over its inventory within a year. VitaNova Life Sciences's Inventory Turnover for the quarter that ended in Apr. 2026 was 12.88.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. VitaNova Life Sciences's Inventory-to-Revenue for the quarter that ended in Apr. 2026 was 0.07.


VitaNova Life Sciences  (OTCPK:VNOV) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

VitaNova Life Sciences's Net-Net Working Capital Per Share for the quarter that ended in Apr. 2026 is

Net-Net Working Capital Per Share (Q: Apr. 2026 )
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(1.597+0.75 * 0.727+0.5 * 0.106-0.396
-0-0)/8.337
=0.22

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

VitaNova Life Sciences's Days Inventory for the three months ended in Apr. 2026 is calculated as:

Days Inventory=Average Total Inventories (Q: Apr. 2026 )/Cost of Goods Sold (Q: Apr. 2026 )*Days in Period
=0.118/1.52*365 / 4
=7.08

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

VitaNova Life Sciences's Inventory Turnover for the quarter that ended in Apr. 2026 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Apr. 2026 ) / Average Total Inventories (Q: Apr. 2026 )
=1.52 / 0.118
=12.88

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

VitaNova Life Sciences's Inventory to Revenue for the quarter that ended in Apr. 2026 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Apr. 2026 ) / Revenue (Q: Apr. 2026 )
=0.118 / 1.785
=0.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.


VitaNova Life Sciences Total Inventories Related Terms


VitaNova Life Sciences Total Inventories Historical Data

* Premium members only.

The historical data trend for VitaNova Life Sciences's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

VitaNova Life Sciences Total Inventories Chart

VitaNova Life Sciences Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25 Apr26
Total Inventories
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.13 0.04 0.11

VitaNova Life Sciences Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Total Inventories Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 0.01 0.01 0.13 0.11
VNOV
51GF Score
VitaNova Life Sciences Corp VNOV
Total Inventories is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

VitaNova Life Sciences Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Frequently Asked Questions Learn more about Total Inventories →
What does a Total Inventories of $0.11 Mil mean?
VitaNova Life Sciences (VNOV) has a Total Inventories of $0.11 Mil as of Apr. 2026. The total amount of inventory as recorded on a company's balance sheet. View historical data for VitaNova Life Sciences and its competitors.
Is VitaNova Life Sciences' Total Inventories too high?
VitaNova Life Sciences' current Total Inventories is $0.11 Mil. Overall, VitaNova Life Sciences has a GF Score™ of 51/100, reflecting its overall financial health beyond just this single metric.
How does VitaNova Life Sciences' Total Inventories compare to HKPD and COSM?
VitaNova Life Sciences' Total Inventories of $0.11 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Medical Distribution company?
A good Total Inventories depends on the Medical Distribution industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for VitaNova Life Sciences and its competitors. VitaNova Life Sciences's current Total Inventories is $0.11 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is VitaNova Life Sciences stock overvalued right now?
VitaNova Life Sciences (VNOV) has a current Total Inventories of $0.11 Mil. The stock's GF Value™ is $5.95, compared to a current price of $1.38 — trading 76.8% below its estimated fair value. The current Total Inventories is $0.11 Mil. VitaNova Life Sciences' overall GF Score™ is 51/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For VitaNova Life Sciences (VNOV), the current Total Inventories is $0.11 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is VitaNova Life Sciences (VNOV) Overvalued in 2026?

Based on GuruFocus' analysis, VitaNova Life Sciences stock appears to be undervalued. The current stock price of $1.38 is trading 76.8% below its estimated GF Value™ of $5.95.

Key valuation signals for VNOV:

  • Total Inventories: $0.11 Mil
  • GF Value™: $5.95 vs. price of $1.38 (76.8% below fair value)
  • GF Score™: 51/100 with 1 warning sign

No single metric tells the full story. See the VNOV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


VitaNova Life Sciences Business Description

Address 30 E Broadway, Suite 603, New York, NY, USA, 10002
VitaNova Life Sciences Corp, formerly Yijia Group Corp provides business consulting services to domestic and international customers. The Company provides consulting services to its clients with regards to funding and other financial matters.The company's operating segments are The consulting services Segment mainly provides consulting advisory services in management, business, accounting and finance; and the Healthcare Segment mainly provides healthcare products and health consultation services to customers. The sale and distribution of healthcare products, such as Nicotinamide Riboside capsules, has only one performance obligation under the fixed-fee arrangements. and the majority of its revenue generates from Sales of healthcare products.
51GF Score

Get the complete analysis for VNOV

Total Inventories is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.38
Price
$5.95
GF Value